Is Enhabit Inc. (EHAB) overvalued? · rev $1.03B
Enhabit Inc. (EHAB) is a medical care facilities company listed on NYSE.
This page asks whether Enhabit Inc. (EHAB) looks expensive on cached numbers — not a short thesis.
Latest reported EHAB revenue for 2024-12-31 was $1.03B. Net income was -$154.0M. Revenue was down 1.1% from 2023-12-31 to 2024-12-31. EHAB currently screens at market cap $706.9M.
EHAB currently screens at market cap $706.9M. A high multiple can be growth prepaid or a bubble. The filing has to explain the gap.
If the next EHAB 8-K cuts growth or raises capex, this “expensive” read gets worse. Until then the SEC page is the source.
Not investment advice. Use the EHAB stock page for the full model, not this heading.
Not investment advice.